Skip to main content

Table 2 The comparison of selected demographic and tumor related characteristics between metastatic and synchronous endometrial disorder and other epithelial ovarian cancer

From: Uterine involvement in epithelial ovarian cancer and its risk factors

Characteristics

Metastatic (N = 136)

Others (N = 211)

P-valuea

Synchronous (N = 37)

P-valueb

Age, yrs.

52.32 ± 11.24

50.65 ± 11.43

0.182

49 ± 11.78

0.117

Pre-menopausal

60 (44.1)

103 (48.8)

0.392

20 (54.1)

0.282

Post-menopausal

76 (55.9)

108 (51.2)

17 (45.9)

Nulliparous

20 (14.7)

39 (18.5)

0.360

11 (29.7)

0.035

Multiparous

116 (85.3)

172 (81.5)

26 (70.3)

Without AUB

126 (92.6)

193 (91.5)

0.694

25 (67.6)

< 0.001

With AUB

10 (7.4)

18 (8.5)

12 (32.4)

Histological ovary type

Serous

124 (91.2)

111 (52.6)

< 0.001

15 (40.5)

< 0.001

Mucinous

3 (2.2)

18 (8.5)

2 (5.4)

Endometrioid

7 (5.1)

54 (25.6)

17 (45.9)

Clear cell

1 (0.7)

19 (9)

2 (5.4)

Unknown

0

2 (0.9)

1 (2.7)

Mixed

1 (0.7)

7 (3.3)

0

Ovary tumor stage

1

0

119 (56.4)

< 0.001

21 (56.8)

< 0.001

2

19 (14)

23 (10.9)

2 (5.4)

3

109 (80.1)

69 (32.7)

14 (37.8)

4

8 (5.9)

0

0

Ovary tumor grade

1

19 (14)

63 (29.9)

0.008

13 (35.1)

0.003

2

32 (23.5)

44 (20.9)

11 (29.7)

3

76 (55.9)

93 (44.1)

9 (24.3)

Unknown

9 (6.6)

11 (5.2)

4 (10.8)

CA125

< 35

6 (4.7)

26 (14.7)

0.005

3 (9.4)

0.303

> 35

122 (95.3)

151 (85.3)

29 (90.6)

CA125

< 100

22 (17.2)

66 (37.3)

< 0.001

11 (34.4)

0.032

> 100

106 (82.8)

111 (62.7)

21 (65.6)

  1. ametastatic uterine involvement and other epithelial ovarian cancer comparison, b metastatic uterine involvement and synchronous endometrial disorder comparison